Based on single-cell-based sequencing data from the GEMs, we observed that the overexpression of MYCN in combination with the loss of Rb1 resulted in the rapid formation of aggressive, metastatic tumors with neuroendocrine-like features. The gene discussed is RB1; the disease is metastatic neoplasm.